Henry Schein Powers Global Healthcare Innovation with a $250 Million Investment Announcement

Henry Schein, Inc. (Nasdaq: HSIC) is excited to announce a significant funding milestone, having successfully raised $250,000,000 in a strategic capital infusion aimed at accelerating our mission to empower health care professionals worldwide. As a leading solutions company for health care professionals, powered by a dynamic network of people and technology, Henry Schein has long been committed to delivering impactful value through more than 300 innovative solutions that enhance operational success and improve clinical outcomes. With approximately 26,000 Team Schein Members globally and a distribution network managing over 300,000 branded products, this infusion of capital reinforces our capability to support over one million customers, ranging from office-based dental and medical practitioners to dental laboratories and institutional clinics. This new funding will be strategically deployed to expand and enhance our Business, Clinical, Technology, and Supply Chain solutions, ensuring practitioners can work more efficiently and deliver quality care more effectively. Embracing cutting-edge technology and operational agility, we plan to invest in advanced digital infrastructure and streamlined distribution systems, further consolidating our position as a trusted advisor in the healthcare industry. As a FORTUNE 500 Company and member of the S&P 500® index, with operations in 33 countries and territories and headquarters in Melville, N.Y., Henry Schein continues to set industry standards. Our impressive growth, highlighted by a 2023 sales figure of $12.3 billion and a compound annual growth rate of approximately 11.5 percent, serves as a testament to our commitment to excellence and innovation in healthcare solutions.